Sociological Study of the Life Courses of Young TRANSgender Patients (ParTransRep)

January 14, 2024 updated by: Mikael AGOPIANTZ, Central Hospital, Nancy, France

Sociological Study of the Life Courses of Young TRANSgender Patients Consulting the REProduction Medicine Department

The number of people consulting for a request related to trans identity is increasing sharply. The study monocentric qualitative study of discursive material aims to describe the diversity of practices and discourses mobilized by the people concerned and their relatives in the wake of work already carried out in the human sciences. Conducting non-directive interviews (life stories) with transgender patients consulting the Reproductive Medicine Department and their volunteer relatives.The ceiling is 20 interviews and 80 hours of observation.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

The number of people consulting for a request related to trans identity is increasing sharply. The study aims to describe the diversity of practices and discourses mobilized by the people concerned and their relatives in the wake of work already carried out in the human sciences.

The care pathway is a central determinant of transgender experiences and differentiated care pathways indicate differentiated relationships to medicalisation and gender, which translate into practices. For the moment, transgender people who do not wish to preserve their fertility or who are not hormonally treated are over-represented in the sample. It is extremely important to gain access to the population that turns to the Reproductive Medicine Service.

The consultation is a place where knowledge (medical, activist, etc.) circulates and meets, which can then be re-appropriated or negotiated by transgender people. While interviews alone are not enough to describe this re-appropriation and negotiation, it is possible to do so through observations of consultations.

Conducting non-directive interviews (life stories) with transgender patients consulting the Reproductive Medicine Department and their volunteer relatives.

The ceiling is 20 interviews and 80 hours of observation.

Patients are given a 'flyer' at the time of their consultation on which the interviewer's contact details are given. They are free to contact the interviewer to find out when and where an interview might take place (outside hospital).

The ceiling is 20 interviews and 80 hours of observation. Discussions during the interview are recorded using a voice recording device, then transcribed in full in Word and anonymised. Discussions during consultations were recorded using notes, then formatted in Word and anonymised.

Study Type

Observational

Enrollment (Estimated)

30

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Young transgender people

Description

Inclusion Criteria:

  • transgender

Exclusion Criteria:

  • Refusal by the patient.
  • Refusal by the patient's legal guardian.
  • Person under guardianship

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Young transgender

Transgender patients consulting the Reproductive Medicine Department for a request related to the preservation of their fertility or hormone therapy, as well as parents/family members present at the time of the appointment.

The ceiling is 20 interviews and 80 hours.

collection of biographical and sociological data. Conducting non-directive interviews (life stories) with transgender patients consulting the Reproductive Medicine Department and their volunteer relatives. Patients are given a 'flyer' at the time of their consultation on which the interviewer's contact details are given. They are free to contact the interviewer to find out when and where an interview might take place (outside hospital).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ethnographic observations of consultations to study relation to care pathway for transgender people
Time Frame: 1 year
Conducting non-directive interviews (life stories) with transgender patients consulting the Reproductive Medicine Department and their volunteer relatives. Patients are given a flyer at the time of their consultation on which the interviewer's contact details are given. They are free to contact the interviewer to find out when and where an interview might take place (outside hospital).
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ethnographic observations of transgender consultations in the Reproductive Medicine Department
Time Frame: 1 year
Ethnographic observations of consultations in the Reproductive Medicine Department. The investigator is present during consultations with transgender patients and takes notes of what he observes and hears. He ensures that those present give their informed consent at the start of the appointment.
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 1, 2024

Primary Completion (Estimated)

August 1, 2024

Study Completion (Estimated)

November 1, 2024

Study Registration Dates

First Submitted

April 6, 2023

First Submitted That Met QC Criteria

January 14, 2024

First Posted (Estimated)

January 24, 2024

Study Record Updates

Last Update Posted (Estimated)

January 24, 2024

Last Update Submitted That Met QC Criteria

January 14, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 2023PI015

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Transgenderism

Clinical Trials on collection of biographical and sociological data

Subscribe